Hypertension, Angiotensin and Neurovascular Regulation
高血压、血管紧张素和神经血管调节
基本信息
- 批准号:7439027
- 负责人:
- 金额:$ 33.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Imbalance within central autonomic networks may contribute to the development or maintenance of hypertension. Hypertension, in turn, exerts deleterious effects on the structure and function of the central nervous system, the cerebral circulation being a major target of these actions. The long-term goals of this project are: (a) to identify the mechanisms by which hypertension alters the regulation of the cerebral circulation during neural activity, and (b) to define how these alterations affect the structure and function of the brain. Project 1 will begin by testing the hypothesis that AngII impairs the mechanisms responsible for the increase in CBF induced by neural activation. In particular, the proposed studies will determine whether Ang II exerts this effect by acting on cerebral blood vessels and by interfering with the vascular mechanisms
through which neural activity increases blood flow. The following specific hypotheses will be tested: (1) Ang II alters the "coupling" between cerebral blood flow and neural activity, (2) this effect is mediated by Ang II-induced production of reactive oxygen species in cerebral blood vessels and nitric oxide inactivation, and (3) NAD(P)H oxidase is a major source of the vascular reactive oxygen species contributing to the dysfunction. Studies will be conducted in mice in which arterial pressure is elevated by administration of Ang II. The increase in cerebral blood flow produced in the somatosensory cortex by whisker stimulation will serve as a model of neural activation. Cerebrovascular responses to endothelium-dependent and independent
vasodilators, and cerebrovascular production of reactive oxygen species will be studied. The role of radicals will be examined using mice overexpressing superoxide dismutase-1. Mice lacking specific NAD(P)H oxidase subunits will be used to determine whether this enzyme is the source of oxidative stress. Transgenic mice overexpressing components of the renin-angiotensin system will also be used in some experiments. The results of these studies will enhance our understanding of the effects of hypertension on the brain and may provide insights into new treatment strategies aimed at counteracting these detrimental actions.
中央自主网络中的不平衡可能有助于高血压的发展或维持。高血压反过来对中枢神经系统的结构和功能产生有害影响,大脑循环是这些动作的主要目标。该项目的长期目标是:(a)确定高血压在神经活动期间改变大脑循环的机制,以及(b)定义这些改变如何影响大脑的结构和功能。项目1将首先检验以下假设:Angii损害了导致神经激活引起的CBF增加的机制。特别是,拟议的研究将确定ANG II是否通过对脑血管作用并通过干扰血管机制来发挥这种作用
神经活动会增加血液流动。将测试以下特定的假设:(1)ANG II改变了大脑血流和神经活动之间的“耦合”,(2)该作用是由Ang II诱导的脑血管中活性氧的产生和氮氧化物失活的活性剂和(3)NAD(3)NAD(P)Hoxidase的主要反应性的氧化物的作用来介导的。将在通过ANG II给药升高动脉压升高的小鼠中进行研究。晶须刺激在体感皮层中产生的脑血流的增加将作为神经激活的模型。对内皮依赖和独立的脑血管反应
将研究血管扩张剂和活性氧的脑血管产生。将使用过表达超氧化物歧化酶1的小鼠检查自由基的作用。缺乏特异性NAD(P)H氧化酶亚基的小鼠将用于确定该酶是否是氧化应激的来源。肾素 - 血管紧张素系统过表达的转基因小鼠也将用于某些实验。这些研究的结果将增强我们对高血压对大脑的影响的理解,并可能提供对旨在抵消这些有害行为的新治疗策略的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Costantino Iadeco...的其他基金
ApoE4, neurovascular injury and cognitive impairment
ApoE4、神经血管损伤和认知障碍
- 批准号:1041935310419353
- 财政年份:2022
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
High-speed imaging of cortical and white matter microvascular flow in AD/ADRD models
AD/ADRD 模型中皮质和白质微血管血流的高速成像
- 批准号:1052328910523289
- 财政年份:2022
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
ApoE4, Neurovascular Injury and Cognitive Impairment
ApoE4、神经血管损伤和认知障碍
- 批准号:1059397910593979
- 财政年份:2022
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Alzheimer's Disease Viewed as a Neurovascular Inflammatory Disorder
阿尔茨海默病被视为一种神经血管炎症性疾病
- 批准号:91950119195011
- 财政年份:2016
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
ApoE4 and mechanisms of diffuse white matter injury
ApoE4 与弥漫性白质损伤的机制
- 批准号:97564829756482
- 财政年份:2016
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
ApoE4 and mechanisms of diffuse white matter injury
ApoE4 与弥漫性白质损伤的机制
- 批准号:93557199355719
- 财政年份:2016
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
ApoE4 and mechanisms of diffuse white matter injury
ApoE4 与弥漫性白质损伤的机制
- 批准号:92646939264693
- 财政年份:2016
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Hypertension and neurovascular dysfunction
高血压和神经血管功能障碍
- 批准号:89086438908643
- 财政年份:2015
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Dietary sodium, neurovascular dysfunction and cerebrovascular risk
膳食钠、神经血管功能障碍和脑血管风险
- 批准号:1029808110298081
- 财政年份:2015
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Hypertension and neurovascular dysfunction
高血压和神经血管功能障碍
- 批准号:99159659915965
- 财政年份:2015
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
相似国自然基金
Ang II调控心脏成纤维细胞CX43并影响其致心律失常性的关键机制研究
- 批准号:81700298
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
盐摄入量改变影响血管紧张素II调控肾远曲小管Kir4.1/Kir5.1通道活性机制的研究
- 批准号:31671196
- 批准年份:2016
- 资助金额:61.0 万元
- 项目类别:面上项目
Ang II和Ang-(1-7)对心房成纤维细胞钙平衡和钙处理相关蛋白的影响和相互作用机制研究
- 批准号:81570302
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
AngII/ARB通过AngIIR/cAMP/PKA途径影响骨质疏松进程研究
- 批准号:81400480
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
纳米粒子介导血管紧张素II的1型受体相关蛋白对大鼠血管内膜增生的影响
- 批准号:81270393
- 批准年份:2012
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
PGI2 restrains immunopathogenesis in hypertension
PGI2 抑制高血压的免疫发病机制
- 批准号:1073140210731402
- 财政年份:2023
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:1059965410599654
- 财政年份:2023
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:1072792910727929
- 财政年份:2023
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Endothelial Piezo1 channel and cerebral blood flow control
内皮Piezo1通道与脑血流控制
- 批准号:1071963310719633
- 财政年份:2023
- 资助金额:$ 33.39万$ 33.39万
- 项目类别:
Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study
肾素血管紧张素系统对阿尔茨海默病过程中 MRI 体积测量和认知功能的影响:LookAHEAD 研究
- 批准号:1044798010447980
- 财政年份:2022
- 资助金额:$ 33.39万$ 33.39万
- 项目类别: